Detalhe da pesquisa
1.
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Ann Oncol
; 29(8): 1822-1827, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897404
2.
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura.
Vox Sang
; 2018 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29786866
3.
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
J Antimicrob Chemother
; 70(11): 3116-23, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316385
4.
[Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients]. / Évènements iatrogènes médicamenteux : impact des consultations pharmaceutiques en cours d'hospitalisation.
Ann Pharm Fr
; 72(6): 440-50, 2014 11.
Artigo
em Francês
| MEDLINE | ID: mdl-25438655
5.
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma.
Ann Oncol
; 24(10): 2618-2623, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23946328
6.
High incidence but low burden of coronaviruses and preferential associations between respiratory viruses.
J Clin Microbiol
; 51(9): 3039-46, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23850954
7.
Cerebral aspergillosis in the era of new antifungals: The CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS).
J Infect
; 84(2): 227-236, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838593
8.
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
J Antimicrob Chemother
; 65(1): 114-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19887460
9.
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
J Antimicrob Chemother
; 65(2): 296-302, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008047
10.
[Erratum to "Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients" [Ann. Pharm. Fr. 72 (2014) 440-450].] / Erratum à l'article « Évènements iatrogènes médicamenteux : impact des consultations pharmaceutiques en cours d'hospitalisation ¼ [Ann. Pharm. Fr. 72 (2014) 440-450].
Ann Pharm Fr
; 73(2): 160-161, 2015 01 08.
Artigo
em Francês
| MEDLINE | ID: mdl-25578947
11.
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.
Clin Microbiol Infect
; 26(6): 781.e1-781.e8, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669427
12.
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
Clin Microbiol Infect
; 26(6): 784.e1-784.e5, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972317
13.
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.
Ann Oncol
; 20(12): 1985-92, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19567453
14.
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
J Antimicrob Chemother
; 64(6): 1274-81, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19841031
15.
Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
J Mycol Med
; 28(1): 8-14, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29534853
16.
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
J Mycol Med
; 28(1): 15-22, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551442
17.
18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
QJM
; 111(9): 613-622, 2018 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29917146
18.
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Clin Microbiol Infect
; 24 Suppl 1: e1-e38, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29544767
19.
Assessment of high-priced systemic antifungal prescriptions.
Med Mal Infect
; 47(6): 382-388, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412043
20.
Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement.
Med Mycol
; 44(Supplement_1): S289-S294, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408917